News
12 Health Care Stocks Moving In Thursday's After-Market Session
18 Apr 24
Movers
12 Health Care Stocks Moving In Thursday's Pre-Market Session
18 Apr 24
Movers
12 Health Care Stocks Moving In Wednesday's After-Market Session
17 Apr 24
Movers
Mustang Bio Expands CAR T-Cell Therapy Platform Expansion Into Autoimmune Diseases
28 Mar 24
Biotech, News, General
Mustang Bio Reports FY23 EPS Of $(6.00) Vs $(10.09) YoY And Recent Corporate Highlights
11 Mar 24
Earnings, News
Phase 1 CAR T Cell Therapy Trial For Glioblastoma At City Of Hope, Demonstrates Clinical Activity Against Incurable Brain Tumors, The IL13Rα2-Targeting CAR T Cell Is Exclusively Licensed By Mustang Bio, A Fortress Biotech Company
7 Mar 24
Biotech, News, Health Care, General
Press releases
Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases
28 Mar 24
Health Care, Press Releases, General
Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade Glioma
7 Mar 24
Press Releases
City of Hope-developed Chimeric Antigen Receptor (CAR) T Cell Therapy Shows Clinical Activity in Patients With Aggressive Brain Tumors in a Phase 1 Trial
7 Mar 24
Press Releases